Practice Management News

MIAMI BEACH, Fla. — Administration of Qelbree for up to 1 year showed similar safety, efficacy and tolerability profiles seen in shorter trials with improvement in ADHD symptoms and executive function, according to a study presented here.

SAN FRANCISCO — Among patients with multiple sclerosis, cognitive function was predicted by age, depressive symptoms and anxiety, according to a poster presented at the American Psychiatric Association annual meeting.

The U.S. government can continue requiring insurance plans to cover services, including HIV prevention and certain cancer screenings, while legal proceedings over Affordable Care Act mandates continue, the Associated Press reported.

MIAMI BEACH, Fla. — Treatment with ketamine may be an effective augmenter of risk mitigation for suicidality and effective modulator for suicide-related cognitive processing in adults, according to data presented here.

Jesse M. Ehrenfeld, MD, MPH, FAMIA, FASA, was recently sworn in as president of the AMA.

SAN FRANCISCO — Compared with children placed in institutional care, those placed in foster care at a young age had better cognitive, physical and psychopathological outcomes through adolescence, according to findings presented here.

From 2017 to 2021, people seeking treatment for opioid use disorder increasingly tested positive for fentanyl, methamphetamine and cocaine at presentation, according to findings published in Addiction.

Recent data showed that an 11-item symptom checklist was effective in identifying substance use disorder severity in primary care, supporting its use as a clinical decision-making tool, researchers reported.

During its House of Delegates meeting, the AMA voted to oppose noncompete agreements for physicians employed by hospitals or staffing company employers.

The FDA has granted 510(k) clearance to Neuronetics Inc. for its obsessive-compulsive disorder motor threshold cap technology for NeuroStar Advanced Therapy for Mental Health.